Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-Announces-Publication-of-Pivotal-Data-from-Phase-3-Clinical-Studies-of-ZERBAXA-Ceftoloza-20266621/?utm_source=whatsapp&utm_medium=social&utm_campaign=share